Client Background:
A top-tier private equity firm was evaluating a $500M acquisition in the rapidly evolving medtech sector. The timeline was tight, and the stakes were high: the firm needed deep, actionable insights to validate the target’s market position, regulatory risks, and growth potential-faster than their competitors.
Solution:
The firm engaged Nextyn’s Expert Network++ (EN++) platform, activating a modular research stack:
- 1:1 Expert Calls: Within 48 hours, EN++ matched the firm with five hyper-specialized medtech experts, including former regulatory officials and market access strategists.
- Offshore Analyst Desk: Simultaneously, an offshore team conducted a rapid market landscape analysis, benchmarking the target against peers and synthesizing recent regulatory changes.
Results:
- Due diligence time reduced by 50% compared to prior deals.
- Actionable insights on regulatory hurdles, reimbursement trends, and competitor moves delivered in under a week.
- The firm confidently submitted a winning bid, citing EN++’s research as a key differentiator in their investment committee memo.
Key Takeaway:
EN++’s modular, on-demand approach enabled the PE firm to outpace rivals, de-risk the deal, and secure a high-value asset with confidence.
